CTNNA1 Familial Expansion Study

Recruiting Observational Study
Cancer Gene Mutation Gastric Cancer Breast Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Abramson Cancer Center at Penn Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of the CAFÉ Study is to determine the cancer risks associated with germline CTNNA1 loss-of-function variants.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age and older * Participants must be carrier, or a first degree relative of a carrier, of a CTNNA1 loss-of-function variant defined as: a variant predicted to lead to protein truncation (nonsense and frameshift variants), a large deletion of one or more exons, or a…
Contacts

Bryson W Katona, MD, PhD

215-349-8222

cafestudy@pennmedicine.upenn.edu

CONTACT

Dana Farengo Clark, MS, LCGC

cafestudy@pennmedicine.upenn.edu

CONTACT